FouNdER mutations confer risk for leukemias

Abstract

In this issue of Blood, Sarasin et al1 and Douglas et al,2 find that homozygous germline founder mutations in genes encoding nucleotide excision repair proteins confer risk for leukemias characterized by TP53 mutations (see figure).